Wong D L, Ciaranello R D
Brain Res. 1985 Dec 9;358(1-2):144-9. doi: 10.1016/0006-8993(85)90958-8.
Dopamine beta-hydroxylase activity is reportedly negligible in malignant rat adrenal cell lines. However, in two pheochromocytoma cell lines, PC12 and PCG2, considerable amounts of this catecholamine enzyme exist but its characteristics differ from the enzyme found in normal rat tissue in two ways. First, in normal adrenal medullary tissue, dopamine beta-hydroxylase activity increases linearly with increasing protein concentration. Second, there is a stringent requirement for copper. Concentrations of copper above or below the optimum inhibit enzymatic activity. In contrast, in pheochromocytoma cells, dopamine beta-hydroxylase exhibits a sigmoidal response with increasing tissue content. At dilute protein concentrations where considerable dopamine beta-hydroxylase activity is observed in normal adrenal medullary extracts, enzymatic activity is negligible in the pheochromocytoma cell lines. As the protein concentration is increased, activation of the enzyme occurs, and enzymatic activity increases linearly with further increases in protein concentration. At very high concentrations of protein, enzymatic activity plateaus. For both PC12 and PCG2 cells, dopamine beta-hydroxylase activity shows minimal copper dependency, suggesting that endogenous inhibitors present in normal tissue are absent in these malignant cell lines. Under conditions of maximum activation, the activity of the enzyme in PC12 cells becomes equivalent to that in normal rat adrenal medulla but remains 45-fold greater than that in PCG2 cells.
据报道,多巴胺β-羟化酶活性在恶性大鼠肾上腺细胞系中可忽略不计。然而,在两种嗜铬细胞瘤细胞系PC12和PCG2中,存在相当数量的这种儿茶酚胺酶,但其特性在两个方面与正常大鼠组织中发现的酶不同。第一,在正常肾上腺髓质组织中,多巴胺β-羟化酶活性随蛋白质浓度增加呈线性增加。第二,对铜有严格要求。高于或低于最佳浓度的铜会抑制酶活性。相比之下,在嗜铬细胞瘤细胞中,多巴胺β-羟化酶随组织含量增加呈现S形反应。在正常肾上腺髓质提取物中观察到相当多多巴胺β-羟化酶活性的稀释蛋白质浓度下,嗜铬细胞瘤细胞系中的酶活性可忽略不计。随着蛋白质浓度增加,酶被激活,酶活性随蛋白质浓度进一步增加呈线性增加。在非常高的蛋白质浓度下,酶活性达到平台期。对于PC12和PCG2细胞,多巴胺β-羟化酶活性显示出最小的铜依赖性,这表明这些恶性细胞系中不存在正常组织中存在的内源性抑制剂。在最大激活条件下,PC12细胞中酶的活性与正常大鼠肾上腺髓质中的活性相当,但仍比PCG2细胞中的活性高45倍。